Last reviewed · How we verify
NCT03171324
to Assess the Effect of Early vs Routine Iron Supplementation on Iron Store and Growth in Term Infants
Phase 4 trial testing Iron Supplement in Iron-deficiency in 300 participants. Status unknown.
30 September 2018
Quick facts
| Lead sponsor | Deepanjan Bhattacharya |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 300 |
| Start date | 1 March 2017 |
| Primary completion | 30 September 2018 |
| Estimated completion | 30 September 2018 |
| Sites | 1 location across India |
Drugs / interventions tested
- Iron Supplement — full drug profile →
Conditions studied
- Iron-deficiency — all drugs for Iron-deficiency →
Sponsor
Deepanjan Bhattacharya
Who can join
Adults 6 Weeks to 1, any sex, with Iron-deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Term infants (Small for Gestational Age and Appropriate for Gestational Age) would be randomized to receive oral iron supplementation from 6 weeks and 6 months. Growth in terms of Occipitofrontal circumference, length and weight would be monitored at 6 weeks, 6 months and 1 year of age. Hemoglobin, RBC (Red blood corpuscles) indices and ferritin would be monitored at 6 months and 1 year of age.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03171324
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Iron Supplement
Trials testing the same drug.
- NCT07095244 — Pediatric Outcomes and Recovery With Peri-Operative Iron Supplement Evaluation · NA · not yet recruiting
- NCT04014855 — Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children · Phase 4 · completed
- NCT03382275 — EXPLorative Data Collection for Patient chAracterIzation, treatmeNt Pathways and Outcomes of IRON Preparations · completed
- NCT03542825 — Oral Lactoferrin Versus Iron Supplementation During Pregnancy · Phase 4 · completed
- NCT03112187 — FLIPS: Ferfer Liposomal Iron Performance Study · Phase 4 · completed
Other recruiting trials for Iron-deficiency
Currently open trials in the same condition.
- NCT05407987 — Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) · Phase 3 · recruiting
- NCT06270498 — Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure · Phase 4 · recruiting
- NCT05913414 — Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma · Phase 2 · recruiting
- NCT05340465 — Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants · Phase 2 · recruiting
- NCT07083492 — Non-invasive Detection of Iron Deficiency in Obstetrics · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03171324 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Deepanjan Bhattacharya
- Last refreshed: 31 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03171324.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing